Gain a comprehensive understanding of the nutritional implications and interventions for patients with acute and chronic pancreatitis in this informative lecture. Led by experts in the field, participants will explore the pathophysiology of acute pancreatitis, including mild, moderate, severe, and necrotizing cases, as well as chronic pancreatitis. The session will cover essential nutrition considerations, including malnutrition, exocrine pancreatic insufficiency, type 3c diabetes, general diet principles, fat intolerance, and the use of nutrition support. With a focus on going back to the basics, this lecture is an excellent opportunity for healthcare professionals to enhance their knowledge and skills in this area. By the end of the session, participants will be equipped with practical tools and resources to improve the nutritional status and outcomes of patients with acute and chronic pancreatitis. Don't miss this chance to deepen your understanding of this critical topic and improve your patient care.
This webinar was presented live on November 3, 2022. The CPE associated with this activity expires on 05/31/2024.
- 8.2.1 Engages in educational activities to maintain knowledge and to obtain new knowledge of diseases and clinical conditions.
- 10.2.1 Selects valid and reliable tools to conduct comprehensive nutrition assessments.
- 10.3.3 Prioritizes specific nutrition problems to inform nutrition care plans and processes.
- Describe the basic pathophysiology of acute and chronic pancreatitis cases.
- Identify "hidden" barriers to communication, whether they be technological, social, cultural or personal.
- Analyze recent evidence regarding route and the use of nutrition support in patients with acute pancreatitis.
Shelby Yaceczko MS, RDN-AP, CNSC, CSSD, CCTD
Shelby Yaceczko is an advanced practice registered dietitian nutritionist specializing in nutrition support, sport nutrition and transplant nutrition. She is finishing her Doctor of Clinical Nutrition degree with a special interest in nutrition optimization for the surgical patient and in the treatment of complex hepatobiliary and pancreatic disease states. Currently she supports the medical oncology and surgical oncology division at UCLA Health in Los Angeles, Calif.